2-Year-Old Girl Flown to the Hospital After Being Bitten on the Face by Family Dog
A two-year-old child in Central Queensland was airlifted to a hospital after being bitten on the face by a family dog
The child was reported to be in stable condition, according to hospital officials
Animal control seized the dog, and an investigation is underway by local authoritiesA two-year-old girl in Australia was flown to a hospital after being bitten on the face by a family dog.
The attack happened just before 11 a.m. in Central Queensland, according to the Australia Broadcasting Corporation. Police and paramedics arrived shortly after and the child was taken to a nearby hospital on a rescue helicopter.
A hospital and health service spokesperson said the child's condition was stable, per the Australian outlet.A spokesperson for Issac regional Council said to ABC that the attack happened on private property and animal control officers were at the house in light of the attack.
'Council takes these matters seriously,' the spokesperson said to the outlet. 'As part of the investigation, the animal involved will be seized and held in council's care pending the outcome of our inquiries.'
Read the original article on People
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Chicago Tribune
30 minutes ago
- Chicago Tribune
Used in COVID shots, mRNA may help rid the body of HIV
The technology that powered COVID vaccines may also lead scientists to a cure for HIV. Using mRNA, Australian researchers said they were able to trick the virus to come out of hiding, a crucial step in ridding the body of it entirely. The research, published last week in Nature Communications, is still preliminary and so far has been shown to be successful only in a lab. But it suggests that mRNA has potential far beyond its use in vaccines as a means to deliver therapies against stubborn adversaries. Short for messenger RNA, mRNA is a set of instructions for a gene. In the case of COVID vaccines, the instructions were for a piece of the coronavirus. In the new study, they are for molecules key to targeting HIV. Dr. Sharon Lewin, director of the Doherty Institute at the University of Melbourne, who led the study, called mRNA a 'miraculous' tool 'to deliver things that you want into places that were not possible before.' Vaccines deploying mRNA instruct the body to produce a fragment of the virus, which then sets off the body's immune response. In the United States, the shots were initially hailed for turning back the pandemic, then viewed by some with suspicion and fear. Some officials, including Health Secretary Robert F. Kennedy Jr., have falsely said that they are highly dangerous and even deadly. Last week, the Department of Health and Human Services sought to limit the vaccine's availability to pregnant women, children and healthy younger adults. The administration also canceled a nearly $600 million contract with the drugmaker Moderna to develop an mRNA shot for humans against bird flu. 'The fear right now is not rational,' Lewin said, adding that 'mRNA vaccines have been given to millions of people around the world, so we have a very good understanding of their risks.' The new study describes the use of mRNA as a tool to flush HIV out of its hiding places. Other uses could involve providing proteins missing from those with certain diseases or correcting genetic errors. Frauke Muecksch, a virologist at Heidelberg University in Germany who was not involved in the work, called mRNA a 'promising, absolutely powerful technology.' Although most people may have only heard of mRNA's use in science during the pandemic, scientists have been working with it for more than 20 years, she said. 'I think it's not just therapeutically very powerful, but also for basic science, for research, it opens up a lot of avenues,' she added. Potent antiretroviral drugs can now control HIV, suppressing it to undetectable levels. Still, minute amounts of the virus lie dormant in so-called reservoirs, waiting for an opportunity to resurge. A cure for HIV would involve ferreting out all of this virus and destroying it, a strategy that has been called 'shock and kill.' A significant hurdle is that the virus lies dormant in a particular type of immune cell, called a resting CD4 cell. Because these cells are inactive, they tend to be unresponsive to drugs. The few drugs scientists have previously used to rouse the virus in these cells were not specific to HIV and had unwanted side effects. 'It's fair to say the field's been a little bit stuck,' said Brad Jones, a viral immunologist at Weill Cornell Medicine who was not involved in the latest research. In 2022, Jones and his colleagues found that the immune boost from the mRNA vaccines awakened latent HIV in people living with the virus. (Other research has shown that mRNA vaccines also activated dormant viruses including Epstein Barr.) 'You get just a little bit of a gentle nudge with some of these vaccines, and it's enough to coax some of these latent viruses out so they can be killed,' Jones said. Lewin and her colleagues had for years experimented with other ways to activate HIV but had no luck in resting cells. Seeing the success of the COVID vaccines, which used lipid nanoparticles — tiny spheres of fat — containing mRNA, her team tested similar particles. They used the particles to deliver two different sets of molecules: Tat, which is adept at switching HIV on, and CRISPR, a tool that can 'edit' genes. The researchers showed that in resting immune cells from people living with HIV, the approach coaxed the virus out of dormancy. 'It's very, very hard to deal with these cells, so I think this really targeting the right population of cells is what makes this paper special,' Muecksch said. It's unclear whether the new approach can successfully awaken all of the dormant HIV in the body, and what side effects it might produce. Lewin said that 'mRNA will almost certainly have some adverse effects, as every drug does, but we will investigate that systematically, as we do for any new drug.' In this case, she said, side effects may be more acceptable to people living with HIV than having to take medications for the rest of their lives. The researchers plan to test the method in HIV-infected animals next, before moving into clinical trials. This article originally appeared in The New York Times.
Yahoo
6 hours ago
- Yahoo
Approach to forever chemicals 'piecemeal, inadequate'
Australia should set up a nationally coordinated program to determine the extent of contamination by forever chemicals to better understand health risks, the nation's distinguished scientists say. A parliamentary inquiry is examining the regulation and management of PFAS and is holding a public hearing in Canberra on Tuesday. PFAS (per and polyfluoroalkyl substances) have been widely used in products including cookware and firefighting foams due to their oil and water repellence and temperature resistance. In a submission, the Australian Academy of Science says the majority of PFAS are highly stable and can persist in the environment for years, with the potential to "contaminate water sources and accumulate in the bodies of humans and animals". The academy has called for monitoring to allow for assessment of the environmental and human risk, to inform management and remediation efforts. "The present piecemeal approach is inadequate," the submission reads. "The extent and distribution of PFAS in the Australian environment are not known. "This is a significant knowledge gap that needs to be filled. There is no nationally consistent methodology and protocols, meaning direct comparisons and useful conclusions from different inputs are sub-optimal." The science academy says it is imperative Australia boosts its monitoring efforts to "inform robust policy responses to address legitimate concerns". Despite Australia having phased out the use of forever chemicals in firefighting foams, the risk of contamination of soil and water remains in areas near airports, defence bases and firefighting training bases. Cancer Council Australia noted the evidence for a causative link between PFAS and cancer is "weak and conflicting", although research is rapidly evolving. The council said there was a need for clearer guidance about the potential risks posed to public health by PFAS contamination and exposure. "A national approach to environmental and human bio-monitoring should be implemented to track long-term trends in the potential health impacts of PFAS," the submission reads. The monitoring of communities in Australia at risk of higher exposure to PFAS is warranted, the Cancer Council says. The inquiry will report in early August.
Yahoo
9 hours ago
- Yahoo
After Doctors Deemed Her Treatment 'Non-Urgent,' 29-Year-Old Woman Receives Unexpected, Life-Threatening Diagnosis
Sarah Graham had only just turned 29 when she was diagnosed with stage 3 bowel cancer, a disease that is becoming more prevalent among younger patients "The first thing I said to [my surgeon] was, 'Am I going to die?' to which he said, 'Look, I hope not,' " Graham recalled about learning of her diagnosis After undergoing chemotherapy and having part of her colon removed, Graham is currently cancer-free, but she remains in a five-year period of surveillanceThe first question that Sarah Graham recalled asking her doctor after being diagnosed with stage 3 bowel cancer days following her 29th birthday was, "Am I going to die?" Her diagnosis came in 2024 after she went to the doctor to discuss a variety of symptoms, including an approximately 44-lb weight gain, extreme pain when going to the bathroom, and blood in her stool. That July, her general practitioner sent her for a stool test, which came back inconclusive, she told Australian news outlet Mamamia. A colonoscopy was recommended, but Graham learned that it had been deemed "non-urgent," meaning that she was unable to schedule it until November. The Australian interior designer's symptoms continued, and she told the outlet that she decided to get a second opinion. This led to her receiving a diagnosis that is becoming more prevalent among people her age. "I explained my symptoms again to her, and said, 'Look, [the blood] is happening almost every time I go to the bathroom now. I'm getting really scared to go to the bathroom,' " she recalled. Graham, who became lactose intolerant at 22 and was diagnosed and treated for endometriosis at 26, said that doctors initially thought that she had "something like Crohn's or Irritable Bowel Syndrome (IBS)." She said that they told her she was "way too young for bowel cancer." However, after undergoing a "traumatic" colonoscopy, Graham said that nurses seemed to be giving her a wide berth in the recovery room. "It was getting to 6 p.m. ... and I was the only one in the recovery room," she said, adding, "And, for some reason, none of the nurses were stopping to talk to me. They were all staring at a distance." Her mom was brought back, and the surgeon finally told her that they had found a mass. Graham was told that she needed "to move quickly" to receive treatment and was scheduled for an "urgent CT scan," with the doctor saying that the mass was "likely malignant." After undergoing additional testing, she was diagnosed with stage 3 bowel cancer."I knew something was wrong [but] I never expected this. I felt let down, I think," she admitted. "I know my body, and I knew what I was living with and no one would listen." Referring to the original doctor, who believed she might be suffering from hemorrhoids or a fissure, Graham wondered "what would've happened" had she waited until November to undergo her colonoscopy. Graham had part of her colon removed and went through six months of chemotherapy. After treatment, she said that she is undergoing surveillance for five years. However, her outlook is "good" at the moment. "They've put me in a low risk of recurrence category but, of course, there is no life free of the burden of cancer, unfortunately," she explained. Now, the designer is sharing a lesson that she hopes others will learn from. "The best piece of advice I was given is that if your doctor says no to something you request, ask them to write that down. You will quickly realize that if they don't want to put their name to denying you something, and something happens later, they don't want to be liable for it," she said, adding, "If anything is out of the ordinary, you need to get it checked." In 2025, the American Cancer Society noted that people under the age of 50 are increasingly being diagnosed with colorectal cancer. The diagnosis is also slightly more deadly than it was in the past. The reason for the diagnosis becoming more prevalent is unclear. However, a study published in April 2025 suggested that there might be a link between children under 10 being exposed to a bacteria in some strains of E. coli. Another 2022 study links colorectal cancer and the rise in ultra-processed foods; however, this is generally in men. Read the original article on People
